On 14-15 March 2018, we will be in Amsterdam, bringing together influencers and innovators from big pharma, biotech, academic and microbiome therapeutic companies to focus on the common goal – unlocking the power of the microbiome for therapeutic applications.
Over 48 hours, our Microbiome Therapeutics Europe meeting delves into how emerging omics and analytical technologies can help to understand and exploit the mechanism of action of microbiome therapeutics.
Join the likes of Janssen, Boehringer Ingelheim, AOBiome, Siolta Therapeutics, Sanofi, Finch Therapeutics, L’Oréal and more for practical industry insight on the latest clinical trials and to explore manufacturing and formulation strategies to take these projects from concepts to market.
Plus, stay abreast of the regulatory framework developments and seek out investment opportunities to take your pipeline to the next level.
Find more here: www.lifesciences.knect365.com/microbiome-therapeutics-europe/
